Divarasib

• Description :

  Divarasib (GDC-6036) (GDC-6036) is an investigational, oral, high-potency and selective KRAS G12C inhibitor with an IC50 of < 0.01 μM. Divarasib irreversibly locks KRAS G12C oncoprotein in an inactive state and inhibits tumor cell growth. It is being investigated for use in solid tumors, including non-small cell lung and colorectal cancers and other types of cancer.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  622.06

• Molecular Formula :

  C29H32ClF4N7O2

• Notes :

  Research use only, not for human use.

• Receptor :

  Kras

• CAS Number :

  2417987-45-0